PharmaShots Weekly Snapshots (Mar 22 – 26, 2021)

 PharmaShots Weekly Snapshots (Mar 22 – 26, 2021)

PharmaShots Weekly Snapshots (Mar 22 – 26, 2021)

Pfizer and BioNTech Initiate COVID-19 Vaccine Trial in Children Under 12

Published: Mar 26, 2021 | Tags: Pfizer and BioNTech, Initiate, COVID-19 Vaccine Trial, Children, Under 12

Tetra Bio-Pharma Initiates Additional Studies of ARDS-003 in Neuroinflammation and Antiviral Diseases

Published: Mar 26, 2021 | Tags: Tetra Bio-Pharma, Initiates, Additional Studies, ARDS-003,  Neuroinflammation, Antiviral Diseases

Immunai Acquire Dropprint Genomics to Expand its Target Discovery Capabilities

Published: Mar 26, 2021 | Tags: Immunai, Acquire, Dropprint Genomics, Expand, Target, Discovery Capabilities

Astellas and Seagen Report EMA’s Acceptance of MAA for Enfortumab Vedotin to Treat Locally Advanced or Metastatic Urothelial Cancer

Published: Mar 26, 2021 | Tags: Astellas and Seagen, Report, EMA, Acceptance, MAA, Enfortumab Vedotin, Treat, Locally, Advanced, Metastatic, Urothelial Cancer

Takeda Reports EMA’s Acceptance of TAK-003 for the Prevention of Dengue

Published: Mar 26, 2021 | Tags: Takeda, Reports, EMA, Acceptance, TAK-003, Prevention, Dengue

BMS Report Results of Relatlimab + Opdivo (nivolumab) in P-II/III RELATIVITY-047 Study in Patients with Previously Untreated Metastatic or Unresectable Melanoma

Published: Mar 26, 2021 | Tags: BMS, Report, Results, Relatlimab, Opdivo (nivolumab), P-II/III RELATIVITY-047 Study, Patients, Previously, Untreated, Metastatic, Unresectable Melanoma


Pfizer and Myovant Report Results of Relugolix Combination Therapy in P-III LIBERTY Withdrawal Study in Women with Uterine Fibroids

Published: Mar 25, 2021 | Tags: Pfizer and Myovant, Report, Results, Relugolix Combination Therapy, P-III LIBERTY, Withdrawal Study, Women, Uterine Fibroids

ProQR Reports Results of QR-421 in P-I/II Stellar Trial for Usher Syndrome

Published: Mar 25, 2021 | Tags: ProQR, Reports, Results, QR-421, P-I/II Stellar Trial, Usher Syndrome

EirGenix Report Results of EG12014 (biosimilar, trastuzumab) in P-III Trial for HER2-Positive Breast Cancer

Published: Mar 25, 2021 | Tags: EirGenix, Report, Results, EG12014 (biosimilar, trastuzumab), P-III Trial, HER2-Positive Breast Cancer


J&J Visions’ Acuvue Theravision with Ketotifen Receives MHLW’s Approval for Vision Correction and Allergic Eye Itch

Published: Mar 25, 2021 | Tags: J&J Visions, Acuvue Theravision, Ketotifen, Receives, MHLW, Approval, Vision Correction, Allergic Eye Itch

Chugai’s Polivy Receives MHLW’s Approval for Relapsed or Refractory Diffuse Large B-cell Lymphoma

Published: Mar 25, 2021 | Tags: Chugai, Polivy, Receives, MHLW, Approval, Relapsed, Refractory Diffuse Large B-cell Lymphoma

AstraZeneca Reports Results of AZD1222 in Primary Analysis of P-III Trial for the Prevention of COVID-19

Published: Mar 25, 2021 | Tags: AstraZeneca, Reports, Results, AZD1222, Primary Analysis, P-III Trial, Prevention, COVID-19

Bayer’s Vitrakvi Receives MHLW’s Approval for the Treatment of NTRK Fusion-Positive Advanced or Recurrent Solid Tumors

Published: Mar 24, 2021 | Tags: Bayer, Vitrakvi, Receives, MHLW, Approval, Treatment, NTRK Fusion-Positive, Advanced, Recurrent, Solid Tumors

Novo Nordisk Presents Results of Semaglutide in P-IIIa STEP 4 Trial to Treat Obesity at ENDO 2021

Published: Mar 24, 2021 | Tags: Novo Nordisk, Presents, Results, Semaglutide, P-IIIa STEP 4 Trial,  Treat, Obesity

Fresenius Medical Care Collaborates with DaVita to Expand the Use of NxStage Home Hemodialysis Machines

Published: Mar 24, 2021 | Tags: Fresenius Medical Care, Collaborates, DaVita, Expand, Use, NxStage Home Hemodialysis Machines

Incyte’s Pemazyre (pemigatinib) Receives MHLW’s Approval for Unresectable Biliary Tract Cancer with a FGFR2 Fusion Gene

Published: Mar 24, 2021 | Tags: Incyte, Pemazyre (pemigatinib), Receives, MHLW, Approval,  Unresectable, Biliary Tract Cancer, FGFR2 Fusion Gene

Zealand’s Zegalogue (dasiglucagon) Receives the US FDA’s Approval for the Treatment of Severe Hypoglycemia

Published: Mar 24, 2021 | Tags: Zealand, Zegalogue (dasiglucagon), Receives, US, FDA, Approval,  Treatment, Severe, Hypoglycemia

Roche Launches New Configurations for Cobas Pro to Increase Testing Efficiency

Published: Mar 24, 2021 | Tags: Roche, Launches, New Configurations, Cobas Pro, Increase, Testing, Efficiency

Regeneron Reports Results of REGEN-COV Antibody Cocktail in P-III Trial to Prevent COVID-19

Published: Mar 23, 2021 | Tags: Regeneron, Reports, Results, REGEN-COV Antibody Cocktail, P-III Trial, Prevent, COVID-19

Novo Nordisk Receives the US FDA’s Refusal to File Letter for Semaglutide to Treat T2D

Published: Mar 23, 2021 | Tags: Novo Nordisk, Receives, US, FDA, Refusal, File Letter, Semaglutide, Treat, T2D

Insulet Presents Results of Omnipod 5 Automated Insulin Delivery System for T1D at ENDO 2021

Published: Mar 23, 2021 | Tags: Insulet, Presents, Results, Omnipod 5 Automated Insulin Delivery System, T1D

Roche Pauses Dosing of Tominersen in P-III GENERATION HD1 for Manifest Huntington’s Disease

Published: Mar 23, 2021 | Tags: Roche, Pauses, Dosing, Tominersen, P-III GENERATION HD1, Manifest Huntington’s Disease

Roche Reports Results of Tecentriq in P-III IMpower010 Study for Patients with Early Lung Cancer

Published: Mar 23, 2021 | Tags: Roche, Reports, Results, Tecentriq, P-III IMpower010 Study, Patients, Early, Lung Cancer

Takeda Collaborates with Evotec on RNA Targeting Drug Development

Published: Mar 23, 2021 | Tags: Takeda, Collaborates, Evotec, RNA Targeting, Drug Development

AstraZeneca’s AZD1222 Meets its Primary Endpoint in Preventing COVID-19

Published: Mar 22, 2021 | Tags: AstraZeneca, AZD1222, Meets, Primary Endpoint, Preventing, COVID-19

BioMarin Report Results of Vosoritide in P-III OLE Study for the Treatment of Children with Achondroplasia at ENDO 2021

Published: Mar 22, 2021 | Tags: BioMarin, Report, Results, Vosoritide, P-III OLE Study, Treatment,  Children, Achondroplasia

BridgeBio Presents Results of Encaleret in P-IIb Study for the Treatment of ADH1 at ENDO 2021

Published: Mar 22, 2021 | Tags: BridgeBio, Presents, Results, Encaleret, P-IIb Study, Treatment,  ADH1

Janssen’s Ponvory (ponesimod) Receives the US FDA’s Approval for the Treatment of Relapsing Multiple Sclerosis

Published: Mar 22, 2021 | Tags: Janssen, Ponvory (ponesimod), Receives, US, FDA, Approval,  Treatment, Relapsing, Multiple Sclerosis

Merck Presents Results of Keytruda (pembrolizumab) + Lenvima (lenvatinib) in P-III KEYNOTE-775/Study 309 trial for the Treatment of Advanced Endometrial Cancer at SGO

Published: Mar 22, 2021 | Tags: Merck, Presents, Results, Keytruda (pembrolizumab), Lenvima (lenvatinib), P-III KEYNOTE-775/Study 309 trial, Treatment, Advanced, Endometrial Cancer

BMS Reports the US FDA’s Acceptance of NDA for Mavacamten to Treat Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Published: Mar 22, 2021 | Tags: BMS, Reports, US, FDA, Acceptance, NDA, Mavacamten, Treat, Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Related Post: PharmaShots Weekly Snapshots (Mar 15 – 19, 2021)

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post